Healthtech & Wellness VC Funds

Crossbeam Venture Partners is a venture capital firm that specializes in investing in pre-seed and Series A startups focused on the future economy. With a strong emphasis on platform economies, fintech, emerging asset classes, and new media, Crossbeam supports innovative companies poised to reshape industries. Notable investments include startups like Spotter, Acquco, and QuickNode, reflecting the firm’s commitment to scalability and high-growth potential. Founded by Ali Hamed and Chris Ryan, Crossbeam goes beyond traditional investing by offering founders strategic guidance, industry connections, and hands-on support. The firm is known for its deep involvement with portfolio companies, helping them navigate the complexities of scaling businesses in competitive sectors such as Web3, remittances, and the creator economy. By focusing on high-potential business models and leveraging its team’s operational expertise, Crossbeam has played a pivotal role in guiding startups through their growth phases. Crossbeam recently raised a $70 million fund, which strengthens its ability to support early-stage companies focused on long-term value creation. The firm operates primarily out of New York and San Francisco, but its investment reach extends globally, particularly in sectors like fintech and logistics. With a reputation for collaboration and adaptability, Crossbeam continues to support visionary founders aiming to redefine the economic landscape.

Crosscut Ventures, based in Los Angeles, is a leading seed-stage venture capital firm. Founded in 2008 by Brian Garrett and Rick Smith, Crosscut focuses on partnering with early-stage founders to build high-growth tech companies. The firm invests in a range of industries including digital media, enterprise SaaS, e-commerce, and fintech. Notable investments in Crosscut's portfolio include companies like GumGum, Pacaso, and SteadyMD. They have also seen successful exits with companies such as HelloTech, Comparably, and StarMaker Interactive. Crosscut typically invests between $250,000 and $750,000 in early-stage companies that have the potential to scale rapidly and disrupt their industries. Crosscut is deeply rooted in the Los Angeles tech ecosystem, leveraging their extensive network and expertise to support startups. They are known for their founder-first approach, emphasizing empathy and long-term partnership. This is reflected in their commitment to founder health and wellness, dedicating at least one percent of all capital invested towards leadership development and mental health support for founders.

Crosslink Capital, founded in 1989, is an early-stage venture capital firm based in Menlo Park and San Francisco. The firm focuses on investing in disruptive and market-transforming companies across enterprise and consumer technology sectors. As of April 2024, Crosslink closed its tenth flagship venture capital fund, Crosslink Ventures X, with $350 million in capital commitments, maintaining its focus on backing early-stage entrepreneurs from pre-seed through Series A stages​. A key component of Crosslink's strategy is the Alpha Network, an invite-only community of over 2,000 founders, CEOs, investors, and operators, established by General Partner Eric Chin in 2005. This network facilitates more than 40 annual events, including thematic discussions, networking parties, investor summits, and conferences, providing a rich ecosystem of support for founders. In conjunction with the recent fundraise, Crosslink has added Anduena Zhubi as the Director of Business Development, aimed at enhancing post-investment support for portfolio companies. Zhubi brings extensive industry experience from her previous roles at Microsoft and its venture arm, M12.

Crossover VC is an early-stage venture capital firm that provides diversified access to high-potential investments in the private technology sector. Founded by Noah Lichtenstein, the firm focuses on backing pre-seed and seed-stage funds, particularly those led by founders and operators with proven track records. Crossover VC is committed to identifying and supporting top technical founders who are poised to lead in their respective sectors. Their investment strategy is deeply rooted in the belief that micro-VC funds, led by experienced operators, will continue to outperform traditional venture capital firms. They are sector-agnostic, though they have a strong preference for post-traction Seed and Series A opportunities where the founding team's unique strengths can significantly accelerate growth. Crossover VC’s portfolio includes investments in innovative companies such as Clubhouse, Life360, and Sundae. With a diverse investor base that includes family offices, financial institutions, tech executives, and even professional athletes, Crossover VC offers a broad network of resources to its portfolio companies. The firm is based in San Francisco and is led by a team of industry veterans who bring decades of experience in both entrepreneurship and investing. This hands-on approach and commitment to fostering long-term partnerships make Crossover VC a key player in the venture capital landscape.

Crowberry Capital, a venture capital firm based in Reykjavik, Iceland, and Copenhagen, Denmark, focuses on seed and early-stage investments in the Nordic region. Founded by Helga Valfells, Hekla Arnardottir, and Jenny Ruth Hrafnsdottir, the firm aims to support innovative and high-potential startups across various sectors, including technology, digital health, and gaming. The firm has raised Iceland’s largest VC fund, a $90 million vehicle, which supports their mission to back diverse and bold entrepreneurs. Crowberry Capital’s portfolio includes notable companies such as Mainframe Industries, a gaming studio developing cloud-native social sandbox MMO Pax Dei; Lucinity, an AI-powered anti-money laundering platform; and Garden.io, which automates cloud development processes. Other investments include companies like Dreamdata, which focuses on B2B revenue attribution, and Kind, a provider of digital communication tools for healthcare providers​. Crowberry Capital prides itself on a strong follow-through philosophy, offering not only capital but also strategic support to help startups scale. Their approach has attracted significant interest from US VC funds at the Series A stage, highlighting the collaborative and robust nature of the Nordic startup ecosystem​.

Crowdcube, founded in 2010, is a UK-based equity crowdfunding platform that enables individuals to invest in startups and growing businesses in return for equity. As a pioneer in this space, Crowdcube democratizes access to investment opportunities, allowing everyday investors to back ventures alongside professional investors. With over 1.1 million registered members, the platform has facilitated the funding of more than 1,000 companies, including notable names like Monzo and Revolut. The platform primarily targets early-stage and growth-stage businesses across diverse industries such as fintech, consumer products, and technology. Crowdcube has raised over $60 million in funding for itself from investors like Balderton Capital and Draper Esprit. In addition to individual investments, it recently launched Cubex, a secondary marketplace for private companies, allowing shareholders to sell their equity before a company goes public. Crowdcube's mission is to give entrepreneurs the capital they need while offering investors the chance to support businesses they believe in, with the added benefit of being part of the company’s journey. It's a leading player in Europe's equity crowdfunding space, continually evolving to meet the growing needs of both founders and investors.

Crush Ventures, the venture capital arm of Crush Music, focuses on early-stage investments at the intersection of media, culture, and technology. With a portfolio that includes 25 companies, Crush Ventures invests in startups poised to impact pop culture significantly. Notable investments include Sound, a blockchain-based music platform, and MELON, a web development company for PC games. Their portfolio also features KYX World, a fashion retail startup, and Audioshake, an AI-driven music technology company. The firm emphasizes supporting ventures that innovate within the music and entertainment industries. Primarily investing in the United States, Crush Ventures leads funding rounds with typical check sizes ranging from $1 million to $5 million. They offer not only capital but also leverage their extensive network and expertise in talent management to provide strategic support. This hands-on approach is evident in partnerships like the one with Dance Church for Sia’s music promotions and the launch of Miley Cyrus’s at-home tan product line, Dolce Glow. The leadership team includes veterans from Crush Music, such as Jonathan Daniel and Bob McLynn, who have a proven track record of building and managing major music talents like Miley Cyrus and Green Day. Their extensive experience in the entertainment industry provides startups with unparalleled access to marketing, branding, and distribution networks. Crush Ventures prefers to invest in innovative, tech-driven startups that align with their focus on pop culture and media. Entrepreneurs looking to partner with Crush Ventures should demonstrate a clear potential to disrupt and engage with mainstream audiences effectively​.

CRV (formerly Charles River Ventures) is a well-established venture capital firm, founded in 1970, that focuses on early-stage investments in both enterprise and consumer technology startups. With over five decades of experience, CRV has supported the growth of more than 600 companies, including major successes like DoorDash, Airtable, Postman, and HubSpot. The firm is known for its hands-on approach and long-term commitment to helping founders build transformative companies. CRV typically leads investments and prides itself on moving quickly, often providing a term sheet within 24 hours. The firm aims to be a founder's first check, backing ambitious projects even in their earliest stages. They invest across various sectors, from enterprise software to consumer products, with notable focus areas like APIs (Postman), cloud networking (Aviatrix), and no-code solutions (Airtable). The firm’s investment ethos is built on forming deep, lasting partnerships with entrepreneurs, helping them navigate challenges and scale their businesses. CRV has offices in San Francisco and Palo Alto, California, with a team of partners experienced in working with startups through both good times and bad.

Crystal Horse Investments (CHI) is a Singapore-based venture capital firm with a focus on early-stage, angel, and seed investments. Established to support innovative startups across Southeast Asia, CHI has built a strong reputation for identifying high-potential companies, particularly in the technology, mobile, gaming, and web-based sectors. The firm actively participates in early funding rounds, including pre-seed, seed, and occasionally Series A, offering startups the critical capital and guidance they need to scale rapidly in competitive markets. Beyond just financial investment, CHI operates as an incubator, providing hands-on mentorship and strategic support to its portfolio companies. Startups benefit from Crystal Horse’s extensive network, industry insights, and operational expertise, allowing them to accelerate growth and navigate common early-stage challenges. The firm also collaborates with government initiatives such as Singapore’s iJam Reload program, which aims to nurture the next generation of tech innovators by providing incubation, mentorship, and early-stage funding opportunities. CHI has backed a diverse range of companies, from mobile app developers to cutting-edge web technology firms. With a strong belief in fostering innovation, CHI is committed to supporting entrepreneurs who are building the future of Southeast Asia’s digital economy. Their flexible investment approach, coupled with deep market knowledge, makes Crystal Horse a valuable partner for startups aiming to disrupt industries and scale regionally.

CSC Upshot Ventures, founded in 2015, is an early-stage venture capital firm based in Palo Alto, California. The firm focuses on providing seed capital to technology companies across sectors like artificial intelligence, fintech, enterprise software, and healthcare. CSC Upshot was formed through a partnership with AngelList and the CSC Group, a Chinese investment powerhouse, making it a unique cross-border fund with a strong connection between U.S. tech innovation and Asian capital markets. CSC Upshot has built a portfolio that includes numerous unicorns, such as Kin, an online platform for homeowner insurance, and Roofstock, a marketplace for real estate investment. The firm has a track record of scaling startups, with investments spanning over 350 companies and several successful exits, including BioAge Labs and OpenGov. CSC Upshot is known for its institutional approach to seed-stage investing, writing initial checks that typically range from $100,000 to $250,000, aiming to bridge the gap between seed and Series A rounds. Led by Ming Yeh and supported by a global team, CSC Upshot leverages its expertise in connecting U.S. and Asian markets, bringing strategic value to its portfolio companies. The firm’s goal is to help founders not only secure capital but also access the global resources needed for long-term growth.

Cultivation Capital is a venture capital firm focused on early-stage investing, primarily at the Seed and Series A phases, with initial investments ranging from $100,000 to $3.5 million. Founded in 2012, the firm manages a family of funds targeting sectors such as life sciences and health tech, software and IT, agriculture and food tech, and geospatial technology. The firm has a mission to advance entrepreneurs with capital, counsel, and support while exceeding investors' expectations and creating opportunities for its team through career advancement and community impact. The firm operates several specialized funds, including partnerships with entities like the Yield Lab for Food and AgTech investments, and has backed over 120 startups. Notable investments include companies in diverse sectors such as therapeutics, diagnostics, precision agriculture, and location intelligence. Cultivation Capital is committed to building an inclusive portfolio, having invested in startups across more than 25 states and countries. The leadership team includes experienced venture capitalists and industry experts like co-founders Cliff Holekamp and Brian Matthews, as well as general partners and advisors with extensive backgrounds in their respective fields. The firm emphasizes active involvement with its portfolio companies, often taking board positions to provide strategic guidance and leverage their network of partners and investors.

Cultivian Sandbox Ventures is a venture capital firm dedicated to investing in innovative startups within the food and agriculture sectors. Founded in 2008 and headquartered in Chicago, the firm focuses on technologies that enhance crop production, animal health, food safety, and sustainability​. The firm has a robust portfolio featuring companies such as Vestaron, which is leading advancements in peptide-based crop protection, Supergut, offering functional food products for gut health, and Sound Agriculture, which develops products to help plants utilize soil nutrients more effectively​​. They also back companies like Geltor, which produces animal-free protein ingredients, and Full Harvest, a B2B marketplace for surplus produce​ (Cultivian Sandbox Ventures)​. Cultivian Sandbox Ventures recently closed its third fund at $135 million, with prominent investors including Archer Daniels Midland, Corteva Agriscience, and Ecolab. This fund focuses on Series A and B deals, with a global investment scope, looking particularly at synthetic biology, AI, and advanced materials​​. The team is led by experienced professionals like Andy Ziolkowski, who has over 30 years in venture capital and merchant banking, and Dan Phillips, who emphasizes the firm's commitment to platform technologies with multiple market applications​.

Cure Kids Ventures (CKV) is a seed and early-stage venture capital fund based in Auckland, New Zealand, established in 2008 as part of Cure Kids, a leading child health research charity. CKV invests in the commercialization of innovations that have the potential to improve child health globally. The fund focuses on healthcare-related sectors, including medical devices, biotechnology, diagnostics, medications, and health information systems. Its mission aligns closely with Cure Kids’ vision of a healthier future for children, supporting solutions that can make a significant impact on pediatric care​. CKV typically invests in pre-seed, seed, and Series A rounds, with initial investments ranging from under $500,000 to $3 million. The fund is highly selective, emphasizing strong commercialization potential. CKV has built an impressive portfolio, backing companies like the a2 Milk Company, Pictor, and The Clinician, which are making waves in health tech and biotech industries. Their investments are strategically aimed at driving innovations that address critical health challenges faced by children. The team at CKV brings global experience in biotechnology and healthcare, providing not only financial backing but also valuable insights into early-stage development and commercialization. CKV has played a crucial role in fostering the growth of New Zealand’s healthcare innovation ecosystem, and its impact extends beyond capital, as it works closely with startups to help them achieve market success.

Cure Ventures, based in Boston, Massachusetts, is a life sciences venture capital firm founded in 2021. The firm focuses on early-stage investments in biotechnology, particularly in new therapeutics. They aim to drive groundbreaking curative technologies from concept to clinical success. Cure Ventures closed their inaugural fund at $350 million, indicating substantial resources dedicated to their mission. The investment strategy at Cure Ventures emphasizes genetic validation to guide drug development, thus increasing the probability of success while reducing the cost of failure. They use a seed funding model to de-risk scientific ventures, with plans to co-lead Series A and B rounds for promising companies. Their hands-on approach involves embedding Cure operators within portfolio companies to assist with day-to-day decision making​. The team at Cure Ventures includes co-founders Richard Lim, David Fallace, and Lou Tartaglia, who bring extensive experience from successful biotech firms like Juno Therapeutics and Agios Therapeutics. Their backgrounds provide a strong foundation for supporting startups through scientific and operational challenges. Notable investments by Cure Ventures include Clasp Therapeutics, Kenai Therapeutics, and Tasca Therapeutics, reflecting their focus on innovative biotechnological solutions. Startups looking to approach Cure Ventures should highlight their potential for breakthrough therapies and be prepared for an intensive, collaborative partnership aimed at achieving significant medical advancements.

CyberAgent Capital (CAC) is a prominent venture capital firm specializing in early-stage investments, particularly in internet and technology-based startups. Founded in 2006 as part of the larger CyberAgent Group, the firm focuses on companies in the seed and early-growth stages. With a strong global network, CAC operates across key markets in Asia, including Japan, China, Taiwan, Indonesia, Vietnam, and Thailand, offering startups a bridge to regional and global expansion. The firm’s investment philosophy centers on incubating and accelerating internet-based businesses. CAC provides deep strategic and operational support, particularly in user acquisition, UI/UX design, and marketing strategies. This hands-on approach allows startups to leverage CAC’s extensive industry knowledge and its connection to the CyberAgent Group, fostering quicker growth in fast-moving markets​. CyberAgent Capital typically invests in startups aiming for global reach and scalability, helping them expand across borders. The firm manages several funds and offers flexible investment sizes depending on the growth stage, supporting companies from the initial idea phase to market expansion​. Some of CAC’s notable portfolio companies include Tokopedia, Coda Payments, and Viddsee, which highlight the firm’s successful track record in backing high-potential tech-driven ventures​.

Cycle Capital, founded in 2009 and headquartered in Montreal, Quebec, is a venture capital firm that specializes in investing in early-stage cleantech companies. The firm aims to support businesses that are developing innovative technologies to create a sustainable future. Cycle Capital manages over CAD 600 million through various funds, targeting sectors such as renewable energy, smart grid technology, energy storage, green chemicals, and advanced materials. The firm's portfolio includes a wide range of companies focused on sustainable innovations. Notable investments include Rhombus Energy Solutions, which develops bi-directional electric vehicle charging infrastructure; Bus.com, an online bus reservation platform; and Airex Energy, which transforms biomass into biochar and biocoal. Other significant investments are in GreenMantra Technologies, which converts waste plastics into specialty polymer additives, and Mysa, which creates smart thermostats for electric HVAC systems. Cycle Capital has also achieved several successful exits, including the acquisition of Rhombus Energy Solutions by BorgWarner in 2022. This acquisition was a significant milestone, showcasing the firm's ability to scale innovative companies to global markets. The firm is led by founder and managing partner Andrée-Lise Méthot, along with a team of experienced partners and venture capitalists. They emphasize long-term collaboration with entrepreneurs, providing both financial support and strategic guidance to help their portfolio companies achieve significant growth and impact.

DAA Capital Partners is a Geneva-based venture capital firm, established to invest in early-stage ventures across technology, consumer goods, and health sectors. Founded with a focus on sustainable growth, DAA Capital provides both financial capital and strategic support to innovative startups in Europe. The firm's investment strategy revolves around Seed and Series A funding rounds, helping young companies scale their operations and realize their potential. Some of DAA Capital’s notable investments include Creal, a company revolutionizing display technologies, Tinamu Labs, which focuses on drone automation, and Smeetz, an AI-driven marketplace platform. The firm leverages its deep industry expertise and global network to offer more than just capital, acting as a strategic partner to help its portfolio companies grow effectively. With a strong commitment to driving innovation, DAA Capital Partners continues to make impactful investments across Europe, emphasizing long-term value creation and responsible growth.

DAAL Ventures is a venture capital firm headquartered in Saudi Arabia, focusing on early-stage investments in the technology sector, particularly in emerging markets. Founded with the mission to bridge international innovation and the Middle East, DAAL plays a pivotal role in helping startups expand into the GCC region, especially Saudi Arabia. The firm is known for providing not only capital but also strategic guidance and mentorship to its portfolio companies. DAAL leverages its extensive regional network and expertise to support startups in various sectors, including fintech, SaaS, artificial intelligence (AI), Internet of Things (IoT), and big data. DAAL Ventures stands out for its collaborative approach, positioning itself as a partner to the companies it backs. This involves helping entrepreneurs scale their operations globally and connecting them with world-class investors and local partners in the Middle East. The firm has invested in a diverse range of startups, including Pulppo, a Mexican proptech platform, and Paym.es, a fintech company, highlighting its commitment to identifying high-potential tech ventures across different regions​. The firm’s vision is to be a leader in tech-focused venture capital in Saudi Arabia and the broader GCC region. DAAL is committed to fostering growth by offering operational support, business development resources, and access to its network of strategic partners. This positions DAAL Ventures as a key player for startups looking to break into the Middle Eastern market​.

Danone Ventures, the corporate venture arm of Danone, is at the forefront of investing in groundbreaking startups within the food and beverage industry. Notable investments include Farmer's Fridge, Harmless Harvest, and Michel et Augustin, demonstrating their commitment to supporting innovative brands that push the boundaries of health and sustainability. With a strategic focus on early-stage companies, Danone Ventures targets sectors such as plant-based products, sustainable food systems, and personalized nutrition. Their geographic reach spans across North America, Europe, and increasingly into emerging markets, showcasing a global outlook with a local touch. Danone Ventures employs a proactive investment strategy, often taking significant stakes and leading funding rounds. They typically invest between $1M and $10M, providing not just capital but also leveraging Danone's extensive resources to help startups scale. The firm has shown consistent activity, with recent investments in companies like Nature’s Fynd and Ready, Set, Food!, highlighting their commitment to innovation and sustainability. The team at Danone Ventures includes experts like Laurent Marcel and Emmanuel Faber, who bring deep industry knowledge and a passion for transforming the food landscape. Startups looking to partner with Danone Ventures should emphasize their innovative approach and alignment with Danone's mission of bringing health through food to as many people as possible. Being approachable and showcasing strong market potential are key to gaining their interest. Danone Ventures is dedicated to fostering a healthier world through strategic and impactful investments.

Daphni Ventures, based in Paris, was founded in 2016 and focuses on early-stage investments with a European DNA and strong international ambition. The firm aims to support companies that contribute to making the world a better place through innovative and disruptive models, emphasizing social and environmental sustainability. Daphni's investment thesis revolves around empowering founders to create a sustainable future by leveraging deep tech and innovation. The firm has made over 80 investments and has seen multiple successful exits, including Shine.fr, Masteos, and Foxintelligence. Their portfolio includes a wide range of companies such as ZOE, a personalized nutrition platform; Double, a remote executive assistant service; and Masteos, a full-stack real estate agency. They also back companies in sectors like edtech, fintech, and health tech, supporting ventures that focus on the circular economy, upcycling, social inclusion, and the future of work. Daphni operates three main investment vehicles: Purple, Yellow, and Dastore, each focusing on different areas of innovation and sustainability. Their approach involves not only providing capital but also offering operational support and access to a community of experts to facilitate collaboration and knowledge-sharing among their portfolio companies.

Darling Ventures is an early-stage venture capital firm based in San Francisco, focusing on providing seed funding to startups with disruptive potential. The firm invests primarily in pre-seed and seed rounds, with check sizes ranging from $50,000 to $250,000. Darling Ventures has built a reputation for backing innovative technology companies, especially in sectors such as digital health, AI, SaaS, fintech, and cloud infrastructure. Their hands-on approach to investing involves closely supporting portfolio companies with growth strategies, market expansion, and preparing for subsequent funding rounds. The firm's portfolio includes startups like Everlywell, Hummingbird, and Berbix, showcasing their commitment to scaling tech-driven solutions in industries with significant growth potential. With a global focus, Darling Ventures leverages its network and expertise to guide founders toward successful outcomes, ensuring they are well-positioned for the next stages of their journey. Founded by Daniel Darling, the firm prides itself on identifying early-stage opportunities in high-growth sectors and helping companies reach product-market fit quickly. Darling Ventures often works as a lead investor but also collaborates with other VCs to maximize the chances of success for the companies in its portfolio. Their strong involvement in their investments sets them apart, offering more than just capital to founders—they bring strategic advice, mentorship, and connections to the table.

Darwin Ventures is a San Francisco-based venture capital fund of funds specializing in providing access to early-stage U.S. venture capital funds, primarily focused on technology, IT, and healthcare. Established to offer selective investments in top-tier VC funds, Darwin leverages diversification across industries to minimize risk while maximizing returns. Their portfolio spans over 100 investments, including partnerships with prominent early-stage VCs. Darwin’s strategy emphasizes investing in multiple funds, reducing the exposure to any single investment. This approach allows investors, particularly institutional and high-net-worth individuals, to benefit from the growth of early-stage startups without bearing the risk associated with direct investments in one company or fund. The firm has successfully raised and deployed five fund-of-funds and manages investments across Series A and B stages. Led by an experienced team with a strong presence in Silicon Valley and the United States, Darwin focuses on long-term forces that shape industries, ensuring their investments align with the technological shifts driving the future economy. They are known for their disciplined and diversified approach, particularly in sectors like health tech and digital infrastructure. The firm’s leadership includes veterans from the venture capital and technology industries, ensuring they are well-positioned to support the success of their partner funds and portfolio companies.

BES Management DAC, in partnership with Davy and BDO, manages the Employment and Investment Incentive Scheme (EIIS) fund, a leading source of capital for Irish SMEs. The fund has a long track record, with over €200 million raised and invested in ambitious Irish businesses over the last 25 years. The EIIS provides individual investors with up to 40% tax relief for investments in qualifying companies, making it a valuable option for both tax savings and supporting local businesses. The fund is sector-agnostic, investing across various industries in all 26 counties of Ireland. Recent portfolio companies include Nutritics, Horizon Offsite, Gym+Coffee, and Connexicon Medical, illustrating its broad focus on tech, health, and consumer services. With an average investment in 6-10 companies per year, BES aligns closely with management teams to help accelerate growth, offering both financial capital and strategic support. For investors, the EIIS is particularly appealing due to the structured diversification across companies, minimizing risk while aiming for solid returns. The fund requires a minimum holding period of four years, making it a medium-term investment with potential for high rewards. Led by seasoned professionals like Ivan Murphy and Sinéad Heaney, BES Management ensures rigorous governance and a hands-on approach to nurturing the growth of Irish enterprises.

Day One Capital, founded in 2011, is a venture capital firm based in Budapest, Hungary, focusing on early-stage technology startups primarily in the Central and Eastern European (CEE) region. They are known for their investments in B2B software companies, leveraging the region's strong talent pool to support technology-driven founders. Day One Capital has built a diverse portfolio across various industries, including AI, fintech, and logistics. Notable investments include Turbine AI, which uses simulated cell technology to enhance drug discovery; Webshippy, a logistics and fulfillment service provider; and Volteum, a company aiding electric vehicle fleet management. They have also backed companies like Colossyan, which specializes in generative AI for video editing, and Commsignia, a leader in automotive IoT​. Their typical investment range is from €300k to €1.5 million for seed and Series A rounds. They have been instrumental in helping companies scale globally, providing not only capital but also strategic support and mentorship from their experienced team, which includes former government officials and seasoned investors​​. Day One Capital continues to foster growth and innovation within the CEE region, contributing significantly to the local startup ecosystem and helping companies achieve successful exits, such as AImotive's acquisition by Stellantis and NOW Technologies' acquisition by Sunrise Medical​​.

Day One Ventures, founded by Masha Bucher in 2018, is a dynamic early-stage venture capital firm based in San Francisco. Known for their unique approach, they combine investment with hands-on PR and communication support, setting them apart in the VC landscape. The fund focuses on industries such as fintech, climate and energy, AI, deep tech, consumer products, and enterprise solutions, with a geographic emphasis on North America and Europe. Their portfolio boasts notable investments in companies like DuckDuckGo, Remote, WorldCoin, and Superplastic. Day One Ventures typically invests between $100K and $1M, often leading seed and Series A rounds. They have a strong track record, with 22 exits and several unicorns under their belt, aggregating over $115 billion in value. Masha Bucher, a Forbes 30 Under 30 honoree and former PR executive, leverages her extensive communications background to provide unparalleled support to portfolio companies, from media strategy to investor introductions. The team, including key members like Drake Rehfeld and Tara Harandi-Zadeh, is deeply involved in every step of the startups' journeys, fostering a close-knit community.

DBL Partners, also known as DBL Investors, is a pioneering venture capital firm that integrates financial returns with social, environmental, and economic benefits—a concept they refer to as the "Double Bottom Line." Founded in 2004 and based in San Francisco, DBL Partners has a strong portfolio that includes high-profile companies such as Tesla, SpaceX, SolarCity, and Pandora. Their investments span sectors like clean energy, sustainable products and services, information technology, and healthcare. DBL's investment strategy is rooted in the belief that strong financial performance and positive social impact are interconnected. This approach is evident in their support for companies like Revolution Foods, which provides healthy meals to schools, and Ecologic Brands, which produces environmentally friendly packaging. DBL assists its portfolio companies not only with capital but also by helping them achieve secondary social and environmental goals, such as creating jobs in underserved communities or reducing carbon footprints. Key team members include Nancy Pfund, who has been instrumental in shaping DBL's impact investment strategy. DBL's focus on nurturing the social aspects of their investments has led to successful outcomes, both in terms of market traction and community benefits. For instance, Pandora's decision to locate its headquarters in Oakland helped revitalize the area and create jobs.

DCM Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm known for its extensive portfolio and successful investments. With over $4 billion under management, DCM focuses on early-stage technology companies across the U.S., China, and Japan. Notable investments by DCM Ventures include companies like SoFi, Careem, Fortinet, and Matterport. These companies highlight DCM’s diverse investment strategy, spanning fintech, cybersecurity, consumer internet, and enterprise software. The firm has also backed companies like Bill.com and Musical.ly (now TikTok), which have seen significant growth and success​​. DCM Ventures operates with a global perspective, investing in the three largest technology markets: the U.S., China, and Japan. This strategic approach has enabled DCM to deliver strong returns to its limited partners, with a focus on early-stage SaaS, fintech startups, and consumer internet companies. The firm has seen numerous successful exits, with 254 companies in its portfolio going public or being acquired​​. The leadership team at DCM includes co-founders David Chao and Xinhe Lin, who guide the firm’s global investment strategy and operational support to its portfolio companies. For startups looking to connect with DCM Ventures, demonstrating innovative solutions in high-growth sectors such as fintech, AI, and cybersecurity can align well with the firm’s investment focus​.

DCP Capital is a leading private equity firm specializing in investments across Greater China and Asia. Founded by former senior partners of KKR and Morgan Stanley, DCP Capital brings together over 26 years of investment expertise in the region. The firm’s leadership team, including Co-Founders David Liu and Julian Wolhardt, has an impressive track record of steering successful investments through multiple economic cycles, focusing on sectors such as consumer goods, industrial technology, healthcare, financial services, and agriculture. DCP Capital raised its debut fund, DCP Capital Partners I, in 2019, closing with over $2.5 billion in commitments. This fund was significantly oversubscribed, attracting top-tier global institutional investors, including sovereign wealth funds, pension funds, and family offices. The firm employs a disciplined, value-oriented investment strategy, targeting both buyouts and significant minority stakes in companies poised for growth and industry consolidation. Their approach emphasizes operational improvements and long-term value creation, which has helped DCP build lasting partnerships with management teams across the region. DCP’s portfolio includes high-profile companies such as Ping An Insurance, Mengniu Dairy, and Adopt A Cow, a disruptive dairy company in China. The firm is known for its deep local knowledge combined with world-class investment expertise, enabling it to identify and capitalize on proprietary opportunities in the dynamic Asian market. By focusing on industries with strong growth potential and by improving operational efficiencies, DCP Capital is well-positioned to continue its success in the private equity landscape.

DCVC (Data Collective Venture Capital) is a deep tech venture capital firm based in Palo Alto, California, founded in 2010 by Matthew Ocko and Michael Driscoll. The firm focuses on investing in groundbreaking technologies that address significant global challenges across various sectors, including artificial intelligence, space, climate, engineering, and more. DCVC manages multiple funds, including DCVC V, which is a $725 million fund aimed at disrupting substantial sectors of the global economy. The firm emphasizes backing startups that employ computational and engineering approaches to solve high-stakes problems. Notable portfolio companies include Pivot Bio, Planet, Zymergen, Atomwise, Rocket Lab, and Recursion Pharmaceuticals, all of which are leaders in their respective industries. DCVC also has a specialized branch, DCVC Bio, co-founded with Dr. John Hamer and Dr. Kiersten Stead, focusing on AI-enabled life sciences platforms. This branch aims to bring new medicines to market and commercialize biological breakthroughs, with companies like AbCellera, Chroma Medicine, and Totus Medicines leading the charge​. The firm’s investment strategy is driven by a belief that venture capital can address urgent global problems profitably and equitably, turning challenges into opportunities while delivering strong returns. DCVC continues to expand its team with experts across various fields to support its growing portfolio and mission​.

Decent Capital, founded in 2007 by Jason Zeng, co-founder of Tencent, is a prominent venture capital firm with a global presence. The firm focuses on early-stage investments across sectors such as SaaS, consumer internet, frontier tech, and sustainable technology, with investments ranging from pre-seed to Series A stages. Decent Capital’s diverse portfolio includes notable companies like Lime, Cider, and Huizuche. Lime is well-known for its smart scooters and bikes aimed at addressing last-mile transportation issues, while Cider is a direct-to-consumer e-commerce platform for fashion. Huizuche, another significant investment, focuses on car rental services in China. The firm has seen successful exits, such as the acquisition of Oculii and Huizuche, and the IPO of FangDD on NASDAQ in 2019. The firm’s investment strategy emphasizes supporting companies through their growth stages with continued capital and strategic guidance. Decent Capital operates from multiple locations, including offices in Shenzhen, Hong Kong, Singapore, and the United States, ensuring a broad reach and impact across various markets.

Deciens Capital is a venture capital firm dedicated to supporting early-stage founders in the financial services sector. Based in San Francisco, the firm focuses on driving digital transformation in long-standing institutions. Their notable investments include Chipper Cash, a leading African fintech; Treasury Prime, a premier banking-as-a-service company; and GlacierGrid, specializing in industrial energy measurement and management solutions. Deciens Capital operates with a highly selective investment strategy, making a limited number of high-conviction investments each year, typically ranging from $500K to $10M per check. The firm's approach centers on being the first significant capital invested in companies that demonstrate increasing returns to scale and deepening competitive moats, often operating in winner-take-all markets. They prefer to be approached with clear, visionary pitches that highlight the potential for significant impact and innovation. The team is led by Daniel Kimerling, a seasoned entrepreneur and investor with a background that includes founding Standard Treasury and working at Silicon Valley Bank. He is recognized in the industry for his expertise and has been named to Forbes’ "30 under 30" and the Milken Institute’s Young Leader Circle. Deciens Capital seeks to provide more than just funding, offering comprehensive support, advice, and valuable relationships to help startups thrive from the earliest stages of their development. They emphasize a collaborative approach, working closely with founders to build the next generation of transformative financial services companies.

Deep Science Ventures (DSV) is a London-based venture studio founded in 2016 that specializes in building science-driven startups across four key sectors: agriculture, computation, climate, and pharmaceuticals. DSV's approach is unique in that it combines scientific knowledge with entrepreneurial expertise to create high-impact ventures from scratch. They partner closely with founder-scientists to tackle some of the world's most pressing challenges, such as reversing global warming, developing curative therapeutics, and advancing computational technologies. DSV's portfolio includes a diverse range of companies, such as Mission Zero Technologies, which focuses on energy-efficient direct air capture of CO2, and Neobe Therapeutics, which is engineering bacteria to improve the efficacy of cancer immunotherapy. These ventures reflect DSV's commitment to creating transformative solutions that are both scientifically rigorous and commercially viable. The firm's model emphasizes de-risking ventures through deep technical and market analysis before significant capital is committed. This methodical approach ensures that the startups they create have a strong foundation for long-term success.

Deepbridge Capital, established in 2010 and headquartered in Chester, UK, focuses on providing growth capital to companies in the technology, life sciences, and renewable energy sectors. Their investment approach emphasizes supporting innovative and high-growth potential companies through various tax-efficient investment opportunities. Deepbridge Capital's portfolio includes a diverse array of companies. Notable investments are in firms like AlgaeCytes, which specializes in producing high-quality EPA oils from algae, and VoxSmart, which provides compliance management solutions for banks. They have also invested in promising startups like Thalia Design Automation, an AI-driven EDA platform, and Ibis Vision, a cloud-based vision testing software for the optical industry. The firm has made 168 investments and has seen 101 exits, showcasing their experience and success in nurturing companies to achieve significant milestones. Deepbridge Capital also supports companies through initiatives such as the Deepbridge Technology Growth EIS Fund and the Deepbridge Innovation SEIS Fund, offering financial backing and strategic guidance to early-stage businesses. The Deepbridge team, led by Managing Partner Ian Warwick, is known for their commitment to fostering innovation and growth across their investment sectors. For more information about their investments and strategic approach, you can visit their official website.

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Define Ventures is a premier early-stage venture capital firm, singularly focused on investing in digital health companies. With a keen eye for transformative potential, Define Ventures partners with innovative entrepreneurs to reshape the healthcare landscape. Their portfolio features notable investments such as Blackbird Health, which is revolutionizing pediatric mental health, and Lightship, a pioneer in decentralized clinical trials. Define Ventures operates primarily within the digital health sector, focusing on business models that integrate technology and healthcare to create scalable solutions. Geographically, they concentrate their efforts within the United States, fostering close relationships with startups that promise substantial impact in the national healthcare system. The firm’s strategy centers on leading early-stage funding rounds, including incubation, seed, Series A, and Series B stages. Define Ventures is renowned for their hands-on approach, providing not just capital but also strategic guidance and industry expertise to help their portfolio companies thrive. The team is led by industry veterans like Lynne Chou O'Keefe, the founder and managing partner, whose vision drives the firm's success. Other key members include A.G. Breitenstein and Frank Williams, both of whom bring extensive experience in healthcare and digital innovation. Define Ventures has recently closed $460 million across Fund III and an Opportunities Fund, cementing its position as a significant player in digital health investment.

Defy Ventures, a New York-based venture capital firm founded in 2010 by Catherine Hoke, focuses on early-stage investments and supporting entrepreneurs, particularly those with unconventional backgrounds such as former convicts. The firm is dedicated to fostering entrepreneurship, employment, and character training for its community. Defy's portfolio includes notable companies such as Nautilus Biotechnology, Empower, and Shujinko. They have made significant investments in various sectors, including high tech, business services, and food and agriculture tech. Recent investments include Monitaur, Writ, and Delivery Collective. The firm values authenticity and the tenacity needed to transform bold ideas into lasting companies. Defy Ventures aims to be the partner of choice for today's daring startup founders, helping them become tomorrow's visionary leaders. They emphasize working behind the scenes to amplify the success of their portfolio companies.

Delin Ventures is a UK-based, mission-driven venture capital firm that focuses on early-stage investments, specializing in two key areas: Life Sciences and the Future of Work & Learning. Established in 2015, the firm backs founders working on breakthrough technologies that can transform healthcare through cell therapies and the future of human work and learning. Delin invests in pre-seed and seed rounds, with typical ticket sizes ranging from €100,000 to €1.5 million, primarily in European startups. In the Life Sciences domain, Delin is committed to advancing cell therapy solutions that can either cure life-threatening diseases or transform them into manageable, chronic conditions. They also invest in the infrastructure necessary for the development and commercialization of these therapies. Notable investments include startups working on innovative therapeutics, medical services, and manufacturing technologies. In the Future of Work & Learning sector, Delin Ventures aims to unlock human potential by investing in technologies that shape the workforce of tomorrow. This includes HR tech, productivity tools, workforce development, and upskilling platforms. They provide hands-on support to founders, leveraging their deep operational expertise and extensive network. The team, led by founder Igor Linshits, includes experts from various industries, ensuring a strong focus on long-term impact. Delin's strategy is centered around making fewer, high-quality investments to ensure that they can offer exceptional support to their portfolio companies, which includes businesses like Fluidic Analytics, Vidsy, and Ori Biotech. The firm is highly selective, providing patient capital and working closely with founders to scale impactful solutions.

Dell Technologies Capital (DTC) is the venture capital investment arm of Dell Technologies, focusing on early-stage investments in the enterprise technology space. Since its inception in 2012, DTC has invested in over 150 companies, helping to propel innovations in data and analytics, cybersecurity, infrastructure, developer tools, and silicon. Their notable portfolio includes industry leaders like DocuSign, MongoDB, and Cylance​. DTC’s investment strategy is to partner with founders from the early stages and provide not only capital but also deep domain expertise and operational support. The firm’s extensive network within Dell Technologies offers startups real customer connections and the opportunity to scale with the backing of a tech giant. Investments typically range from seed to growth stages, with DTC often leading the rounds​. Headquartered in Palo Alto, California, DTC’s team of investors, technologists, and operators work closely with portfolio companies, guiding them from inception to market leadership. This hands-on approach ensures that the startups benefit from strategic insights and operational know-how, positioning them for successful exits​​. Overall, Dell Technologies Capital stands out for its commitment to fostering groundbreaking enterprise technologies and its robust support system for startups aiming to disrupt the tech landscape.

Delphi Ventures, founded in 1988, is a venture capital firm based in San Mateo, California. The firm focuses primarily on life sciences, including biotechnology, medical devices, and healthcare IT. Over the years, Delphi Ventures has made significant contributions to the life sciences industry with over 318 investments and 190 exits. Notable investments by Delphi Ventures include Revance Therapeutics, Senseonics, and PTC Therapeutics. These companies have developed innovative solutions in neurotoxin aesthetics, continuous glucose monitoring, and treatments for rare diseases, respectively. Revance Therapeutics, for instance, is now a public company with significant revenue, reflecting Delphi Ventures' ability to identify and nurture high-potential startups. Delphi Ventures' investment strategy is centered on early and growth-stage investments, with a focus on supporting pioneering technologies and therapies. The firm has a strong track record of successful exits, including companies that have gone public such as EBR Systems and Senseonics, as well as several notable acquisitions like Seattle Genetics and Acclarent. The team at Delphi Ventures is led by experienced professionals such as Deepa Pakianathan, Douglas Roeder, and founder James Bochnowski. Their expertise and deep industry knowledge play a critical role in guiding portfolio companies toward successful growth and market leadership.

Delta Partners is a Dublin-based venture capital firm specializing in early-stage investments in technology companies. Founded in 1994, the firm has a strong track record with over 140 investments and €1.8 billion in exit returns. Delta Partners focuses on seed and Series A investments, supporting companies from their foundation stage through to successful scaling and exits. They emphasize building solid company foundations and capital-optimizing cultures to increase the likelihood of success. The Delta team includes experienced partners like Dermot Berkery, Maurice Roche, Amy Neale (formerly of Mastercard), and Richard Barnwell (founder of Digit Games). They are committed to integrating sustainability risks into their investment process, ensuring that environmental, social, and governance (ESG) factors are considered throughout the lifecycle of their investments. Delta Partners operates with a partner-led approach, providing startups with direct access to senior-level experience from the first conversation. This hands-on support helps entrepreneurs navigate their journey from seed to Series A and beyond.

Demeter, a major European player in venture capital, private equity, and infrastructure, focuses on investments that drive the energy and ecological transition. Founded in 2005, Demeter manages €1.3 billion across its funds and has completed over 230 investments. The firm targets innovative startups, SMEs, and infrastructure projects, offering investments ranging from €1 million to €30 million. Notable investments include McPhy Energy, which specializes in hydrogen production, storage, and distribution technologies, and Ynsect, which produces environmentally friendly insect-based products. Demeter also supports companies like Sunna Design, which develops solar LED lighting solutions, and Sweetch Energy, a renewable energy firm focusing on osmotic energy. One of Demeter's significant initiatives is the recent launch of a €500 million fund in collaboration with EIT InnoEnergy. This fund aims to develop a resilient and diverse battery raw material supply chain for Europe, addressing the continent's growing demand for batteries and supporting the European Battery Alliance's goals. Demeter's investment strategy is driven by a commitment to sustainability, evident in their support for green projects like H2 Green Steel, the world's first integrated large-scale green steel plant. The firm's dedication to environmental responsibility is further reflected in their involvement in initiatives like the Climate Dividends program, which promotes sustainability across their portfolio companies.

Derayah Ventures is a Saudi-based venture capital firm that invests in early to growth-stage startups across the MENA region. Launched in 2019, the firm manages a $30 million fund focused on technology-driven businesses, particularly in sectors such as SaaS, fintech, eCommerce, artificial intelligence, Internet of Things (IoT), and marketplace platforms. Derayah primarily backs companies that are either disrupting traditional industries or organizing them through innovative solutions. The firm’s investment philosophy centers on supporting scalable startups with high growth potential and strong teams. Derayah Venture Capital provides not just financial backing but also strategic guidance to help companies expand within the MENA region, especially into Saudi Arabia. The fund focuses on post-seed, pre-Series A, and Series A stages, enabling startups to access critical capital during their early development phases. Led by a team of experienced investors, including Chairman Faris Ibrahim AlRashed, Derayah aims to build tomorrow's market leaders through a combination of capital, industry expertise, and strong local networks.

Designer Fund is a San Francisco-based venture capital firm founded by Ben Blumenrose and Enrique Allen, specializing in seed-stage investments in design-led startups. Notable investments include Omada Health, Gusto, and Stripe, companies recognized for their innovative design approaches and user-friendly interfaces. The fund primarily targets industries like financial services, healthcare, and sustainability, aiming to replace legacy systems with more efficient, user-centered solutions. Designer Fund focuses geographically on the US, with a strong presence in the Bay Area. Their strategy involves making significant contributions to seed rounds, typically around $500,000, while often not leading. They invest in about eight companies annually, allowing them to provide extensive design support through their Designer Fund Partnership. This support includes monthly design sessions, professional development workshops, and access to a community of top designers and founders. The team at Designer Fund is led by seasoned experts like Blumenrose, with extensive experience at Meta, and Allen, who has a background with Facebook’s fbFund and 500 Startups. Their collaborative approach and deep integration within the design community make them a valuable partner for startups aiming to scale their design capabilities and impact.

Detroit Venture Partners (DVP), founded in 2010 by Dan Gilbert, is a venture capital firm committed to backing early-stage tech startups that aim to drive innovation and economic growth. Based in Detroit, DVP is part of the broader Rock Family of Companies, which includes Rocket Companies, Bedrock Detroit, and the Cleveland Cavaliers. This extensive network enables DVP to offer its portfolio companies not only financial backing but also strategic partnerships and resources to help them scale effectively. DVP focuses on investing in startups that embody creativity, grit, and passion. They have a strong emphasis on companies in the technology sector, including fintech, SaaS, and logistics. Some of their notable portfolio companies include StockX, Livegistics, 100 Thieves, and CoverTree. By fostering innovation, DVP contributes to Detroit’s entrepreneurial ecosystem, helping to rejuvenate the city’s long history of industrial innovation. In addition to their investment activities, DVP runs a Summer Fellowship program that offers MBA and undergraduate students hands-on experience in venture capital and early-stage startups.

Devlabs is a micro venture capital firm with a focus on early-stage investments in North America, South America, and the Caribbean. Established in 2013 and headquartered in Oakland, California, and Temuco, Chile, Devlabs manages an $8 million fund dedicated to pre-seed investments in software startups, with plans to close a $21 million fund for agriculture and renewable energy sectors​. The firm typically invests between $100,000 and $300,000 per company in exchange for 5-15% equity, targeting industries such as B2B software in agri-business, finance, health, tourism, education, and operations​. Devlabs focuses on high-impact, high-growth tech entrepreneurs, especially those addressing multi-billion dollar problems with market-driven solutions. Devlabs was co-founded by Jose D Lopez and Ruben Hernandez, both of whom bring over 20 years of experience in venture capital, software development, and business innovation​ (devlabs)​. The firm leverages its extensive network and experience in emerging markets to reduce barriers and costs for investment, aiming to support lean, early-stage companies and help them scale rapidly.

DG Daiwa Ventures, a Tokyo-based venture capital firm founded in 2016, is a joint venture between Digital Garage and Daiwa Securities Group. The fund focuses on early-stage investments in cutting-edge technologies, such as blockchain, artificial intelligence (AI), cybersecurity, biohealth, and extended reality (xR). DG Daiwa Ventures operates globally, with a special emphasis on startups in Japan and the broader Asia-Pacific region. The firm manages two main funds: DG Lab Fund I and DG Lab Fund II, which collectively manage over 20 billion yen. These funds target high-potential tech startups by leveraging the combined expertise and incubation capabilities of both Digital Garage and Daiwa Securities. DG Daiwa Ventures has a track record of nurturing successful startups, such as Goodpatch and Akili Interactive Labs, which have gained recognition for their innovative products. DG Daiwa is known for supporting its portfolio companies with strategic resources and helping them scale through partnerships, additional fundraising, and IPO support. The firm aims to identify companies that can drive technological advancements and create substantial returns for investors through a global network of partners and later-stage investors.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

Diagram is a venture capital firm and venture builder based in Montreal and Toronto, with over $350 million in assets under management. Launched in 2016, Diagram focuses on Fintech, Web3, and ClimateTech industries. It stands out for its hands-on approach, where it not only provides capital but also actively collaborates with founders to build and launch companies. Since its inception, Diagram has helped launch over 20 ventures, raising more than $500 million across its portfolio, and creating substantial shareholder value. The firm's investment model centers on early-stage companies, providing founders with access to its extensive global network of investors, operators, and industry leaders. This helps accelerate the growth and success of its portfolio companies. Notable investments in Diagram's portfolio include companies like WorkOS, Weights & Biases, and CitadelID. Diagram combines its venture building expertise with strategic investments, making it a strong player in supporting companies from idea to execution in their respective markets​.

Diamond Capital is a venture capital firm based in Taiwan, primarily focusing on investments in the biotechnology, medical, and high-tech sectors. Established in 2013, the firm has built a strong reputation for nurturing innovative companies that are driving advancements in healthcare, new drug development, high-end medical equipment, and innovative medical services. Diamond Capital is known for its strategic investments that span early to growth-stage companies, particularly those operating in Asia. The firm is particularly noted for its involvement in the biotechnology sector, where it has been instrumental in supporting startups that have gone on to achieve significant milestones, including public listings. Diamond Capital's strategy involves not only providing capital but also leveraging its extensive network and expertise to guide companies through the complexities of scaling and entering global markets. This approach has made it a key player in Taiwan’s venture capital landscape. In 2023, Diamond Capital made headlines by becoming the first biotech venture capital firm to list on the Taiwan Stock Exchange, further enhancing its visibility and credibility on the international stage. The firm's portfolio includes a diverse array of companies, from cutting-edge biotech firms to innovative medical device manufacturers, all of which are united by their potential to make significant contributions to their respective fields.